Duration of circulating and secretory antibody and cell-mediated immunity following immunization
- PMID: 1126572
Duration of circulating and secretory antibody and cell-mediated immunity following immunization
Abstract
An important consideration in evaluating vaccines is the duration of immunity. The only really important measure of this immunity is the protection against infections and/or illness at various time intervals, following natural or artificial challenge. There are few data of this sort, more commonly immunity is estimated by measuring serum antibody, in many instances an erroneous measure. Serum antibody levels to respiratory viruses fall only slightly 6 months following infection or immunization. It is difficult to assess the duration of antibody for much longer than this, because of problems with intercurrent infection. With respiratory bacterial infections, e.g. pneumococcal pneumonia, parenterally-induced immunity probably lasts for only several months. Secretory antibody induced by inactivated viral vaccines, seems to persist for about a year, after having reached a peak level at about 4-6 weeks following immunization. Work with the live attenuated polio virus vaccine indicates longer lasting immunity, with detectable antibody persisting for up to 34 months. Restimulation with the inactivated polio virus vaccine produced no evidence of a secondary response (memory). Following booster immunization with influenza very little evidence of memory is seen. Cell-mediated immunity (CMI): in guinea pigs BCG sensitization can be demonstrated for at least 2-9 months. In humans, intracutaneous BCG immunization leads to positive tuberculin reaction in 6-10 weeks, and skin sensitivity lasts an average of about 4 years. There is contradicting data as to the duration of protection against infection following BCG immunization. Local and systemic CMI have been shown to exist independently of each other in experimental animals and man.
Similar articles
-
Immunologic and virologic aspects of secretory immune system in human respiratory tract.Dev Biol Stand. 1975;28:129-44. Dev Biol Stand. 1975. PMID: 47823
-
Assessment of resistance to influenza virus infection in animal models.Dev Biol Stand. 1975;28:307-18. Dev Biol Stand. 1975. PMID: 1126574
-
Vaccination by non-parenteral routes: characteristics of immune response.Dev Biol Stand. 1976;33:19-26. Dev Biol Stand. 1976. PMID: 782968
-
The immune response to influenza vaccines.Acta Virol. 1990 May;34(3):295-304. Acta Virol. 1990. PMID: 1980401 Review.
-
Keeping the memory of influenza viruses.Pathol Biol (Paris). 2010 Apr;58(2):e79-86. doi: 10.1016/j.patbio.2010.01.010. Epub 2010 Mar 19. Pathol Biol (Paris). 2010. PMID: 20303671 Review.
Cited by
-
Use of a solid-phase radioimmunoassay and formalin-fixed whole bacterial antigen in the detection of antigen-specific immunoglobulin in prostatic fluid.J Clin Invest. 1981 Mar;67(3):790-9. doi: 10.1172/JCI110096. J Clin Invest. 1981. PMID: 7009649 Free PMC article.
-
[A new influenza subunit vaccine: hemagglutinating antibodies one year after vaccination (author's transl)].Infection. 1978;6(5):217-20. doi: 10.1007/BF01642312. Infection. 1978. PMID: 365774 Clinical Trial. German.